We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

AXA Diagnostics Srl

AXA Diagnostics offers a wide range of products, systems and services for laboratory specialists to help diagnose sev... read more Featured Products: More products

Download Mobile App





AXA Diagnostics Highlights SkyLAB752 System

By LabMedica International staff writers
Posted on 05 Feb 2018
AXA Diagnostics (Milan, Italy) participated in MEDLAB Middle East, the world’s largest attended laboratory & IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE. More...
AXA Diagnostics shared the booth with its sister company, Sclavo Diagnostics Int., where it provided all updates and new applications of its SkyLAB752 automated ELISA/IFA processor. Sclavo is a leading manufacturer of reagents for clinical chemistry, specific/urinary proteins, coagulation, and serology.
 
AXA Diagnostics is a partner to DASIT Group, which also comprises other leading IVD organizations, such as DASIT S.p.A. and industrial and research laboratories, such as CARLO ERBA Reagents S.r.l. and FASTER S.r.l. AXA Diagnostics develops, produces and markets IVD reagents dedicated to autoimmunity disease and instruments for the automation of all ELISA and IFA testing. The company also provides OEM equipment to fulfill the needs of automating the processing of IVD reagents.
 
The SkyLAB752 automated ELISA/IFA processor from AXA Diagnostics can simultaneously process ELISA microplates and IFA slides. The system is equipped with two innovative dispensing systems able to work simultaneously and independently. This enables the instrument to pipette an entire microplate in half the time compared to other analyzers available on the market. The movement of the manifold robotic arm does not interfere with the movement of the other two robotic arms, pipettes and microplate robotic arm, making the dispensing, washing and reading steps independent of each other. This architecture allows to maintain the execution times of each processing step aligned with the directions provided on the kit's IFU, leading to elimination of any drift effect.
 
Its innovative design allows constant access to the microplates by the washer and pipettes, even during incubation, so that the whole procedure applied to each strip can be closely followed and monitored. The SkyLAB 752 uses a LED microplate reading system that allows precision, reduced maintenance and a 3.3 OD photometric range. A state of the art LED light-source provides high performance and minimum maintenance, large measurement range and excellent reproducibility.
 
The system accommodates five positions on the working area equipped with incubators. Under the working area, two additional positions are available, one of them equipped with a shaker incubator. Each of the seven positions can contain both microplates and IFA slides. As an optional under the working area, SkyLAB 752 can accommodate from one to four positions equipped with incubators and shakers that can contain both microplates and IFA slides.
 

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
All-in-One Molecular System
AIO M160
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.